1. Home
  2. OPK vs GB Comparison

OPK vs GB Comparison

Compare OPK & GB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPK
  • GB
  • Stock Information
  • Founded
  • OPK 2007
  • GB 1980
  • Country
  • OPK United States
  • GB Switzerland
  • Employees
  • OPK N/A
  • GB N/A
  • Industry
  • OPK Biotechnology: Pharmaceutical Preparations
  • GB EDP Services
  • Sector
  • OPK Health Care
  • GB Technology
  • Exchange
  • OPK Nasdaq
  • GB Nasdaq
  • Market Cap
  • OPK 1.1B
  • GB 1.5B
  • IPO Year
  • OPK 1995
  • GB N/A
  • Fundamental
  • Price
  • OPK $1.34
  • GB $7.36
  • Analyst Decision
  • OPK Buy
  • GB Buy
  • Analyst Count
  • OPK 4
  • GB 1
  • Target Price
  • OPK $2.75
  • GB $6.00
  • AVG Volume (30 Days)
  • OPK 3.3M
  • GB 44.6K
  • Earning Date
  • OPK 08-06-2025
  • GB 08-27-2025
  • Dividend Yield
  • OPK N/A
  • GB N/A
  • EPS Growth
  • OPK N/A
  • GB 483.33
  • EPS
  • OPK N/A
  • GB 0.38
  • Revenue
  • OPK $689,408,000.00
  • GB $548,939,689.00
  • Revenue This Year
  • OPK N/A
  • GB $15.17
  • Revenue Next Year
  • OPK $6.98
  • GB $6.50
  • P/E Ratio
  • OPK N/A
  • GB $19.46
  • Revenue Growth
  • OPK N/A
  • GB 20.26
  • 52 Week Low
  • OPK $1.21
  • GB $4.29
  • 52 Week High
  • OPK $2.04
  • GB $8.00
  • Technical
  • Relative Strength Index (RSI)
  • OPK 51.42
  • GB 40.38
  • Support Level
  • OPK $1.32
  • GB $7.45
  • Resistance Level
  • OPK $1.36
  • GB $7.36
  • Average True Range (ATR)
  • OPK 0.04
  • GB 0.04
  • MACD
  • OPK 0.00
  • GB -0.01
  • Stochastic Oscillator
  • OPK 65.38
  • GB 31.82

About OPK OPKO Health Inc.

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.

About GB Global Blue Group Holding AG

Global Blue Group Holding AG offers a seamless shopping and payment journey for tourists and also provides a wide range of Added-Value Payment Solutions for all the stakeholders involved, including retailers and international shoppers. The company connect thousands of retailers, acquirers, and hotels with nearly 80 million consumers across more than 50 countries, in three industries: Tax Free Shopping, Payments and Post-Purchase solutions.

Share on Social Networks: